Literature DB >> 27347122

Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens.

Qiubo Yu1, Yanan Li1, Gang Li1, Tinghong Li1, Han Zeng1, Zhu Yang1, Deling Wang2.   

Abstract

The aim of the present study was to estimate the diagnostic value of fluorescence in situ hybridization (FISH) analysis of tumor cells in voided urine specimens for detecting upper tract urothelial carcinoma (UTUC). Cytology and FISH analyses were conducted on voided urine collected in the morning from 125 patients with suspected UTUC. During follow-up, ureteroscopy with biopsy and histopathology were used to confirm the presence of tumors. The average follow-up time was 23.8 months (range, 6-36 months). A total of 8 patients who could not be contacted until the last follow-up were excluded from the study. Of the remaining 117 patients, 19 were histologically demonstrated to have UTUC, of whom, 3 patients had stage pTis disease, 6 had stage pTa disease, 5 had stage pT1 disease and 5 had stage pT2 disease (7 G1, 8 G2 and 4 G3). The overall sensitivity of FISH to detect UTUCs in voided urine specimens was 84.21% (16/19), whereas that of cytology was 42.11% (8/19) (P<0.05). The overall specificity of FISH to detect UTUCs in voided urine specimens was 89.80% (88/98), compared with 94.90% (93/98) of cytology (P>0.05). The positive predictive value (PPV) and negative predictive value of FISH were 80.00% (16/20) and 97.78% (88/90), respectively, whereas those of cytology were 100.00% (8/8) (P>0.05) and 90.29% (93/103) (P>0.05), respectively. The present data indicated that FISH was a method capable of detecting UTUCs in voided urine specimens with good sensitivity and specificity, although it exhibited a high rate of false positivity and low PPV.

Entities:  

Keywords:  fluorescence in situ hybridization; prospective; upper tract urothelial carcinoma; voided urine specimen

Year:  2016        PMID: 27347122      PMCID: PMC4906663          DOI: 10.3892/ol.2016.4592

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report.

Authors:  M Lodde; C Mian; H Wiener; A Haitel; A Pycha; M Marberger
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

2.  Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.

Authors:  Bin Luo; Wen Li; Chun-Hua Deng; Fu-Fu Zheng; Xiang-Zhou Sun; Dao-Hu Wang; Yu-Ping Dai
Journal:  Cancer Genet Cytogenet       Date:  2009-03

3.  Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary--Japanese Urological Association, 2014 edition).

Authors:  Mototsugu Oya; Eiji Kikuchi
Journal:  Int J Urol       Date:  2014-09-21       Impact factor: 3.369

4.  Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

Authors:  H G Wiener; C Mian; A Haitel; A Pycha; G Schatzl; M Marberger
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

5.  Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Authors:  Jordan P Reynolds; Jesse S Voss; Benjamin R Kipp; R Jeffrey Karnes; Aziza Nassar; Amy C Clayton; Michael R Henry; Thomas J Sebo; Jun Zhang; Kevin C Halling
Journal:  Cancer Cytopathol       Date:  2014-03-06       Impact factor: 5.284

6.  A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.

Authors:  Grant D Stewart; Simon V Bariol; Ken M Grigor; David A Tolley; S Alan McNeill
Journal:  BJU Int       Date:  2005-04       Impact factor: 5.588

7.  Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract.

Authors:  H Zincke; J J Aguilo; G M Farrow; D C Utz; A U Khan
Journal:  J Urol       Date:  1976-12       Impact factor: 7.450

8.  Evaluation of upper urinary tract tumors by FISH in Chinese patients.

Authors:  Zhengfei Shan; Peng Wu; Shaobin Zheng; Wanlong Tan; Haikuan Zhou; Yi Zuo; Huan Qi; Peng Zhang; Hongmei Peng; Yanfen Wang
Journal:  Cancer Genet Cytogenet       Date:  2010-12

9.  Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.

Authors:  Thomas Akkad; Andrea Brunner; Leo Pallwein; Christian Gozzi; Georg Bartsch; Gregor Mikuz; Hannes Steiner; Irmgard Verdorfer
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

Review 10.  Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.

Authors:  Ruta Gupta; Gladell P Paner; Mahul B Amin
Journal:  Adv Anat Pathol       Date:  2008-05       Impact factor: 3.875

View more
  4 in total

1.  Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.

Authors:  Amir Hossein Aalami; Farnoosh Aalami
Journal:  Int J Clin Oncol       Date:  2022-07-18       Impact factor: 3.850

2.  Utility of Fluorescence In Situ Hybridization (FISH) to Sub-Classify Low-Grade Urothelial Carcinoma for Prognostication.

Authors:  Yi Chen; Bo Tao; Ya Peng; Weijiao Yang; Chuang Wang; Xuebao Xiang; Tianyu Zhang; Li Gao; Jiaoyu Yi; Xiangfu Zhou; Jiefu Huang
Journal:  Med Sci Monit       Date:  2017-06-28

3.  Diagnostic Value Comparison of Urothelium Carcinoma Among Urine Exfoliated Cells Fluorescent In Situ Hybridization (FISH) Examination, Computerized Tomography (CT) Scan, and Urine Cytologic Examination.

Authors:  Tao Yang; Yan Li; Jing Li; Junjiang Liu; Xinna Deng; Gang Wang
Journal:  Med Sci Monit       Date:  2018-08-19

Review 4.  Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma-A Systematic Review.

Authors:  Łukasz Białek; Konrad Bilski; Jakub Dobruch; Wojciech Krajewski; Tomasz Szydełko; Piotr Kryst; Sławomir Poletajew
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.